What is the purpose of this trial?
The investigators hypothesize that treatment with the iron chelator, Deferoxamine Mesylate, improves the outcome of patients with brain hemorrhage.
The purpose of this study is to determine whether treatment with Deferoxamine Mesylate is of sufficient promise to improve outcome before pursuing a larger clinical trial to examine its effectiveness as a treatment for intracerebral hemorrhage.
Ages: 18 - 80 years
Beth Israel Deaconess Medical Center
Dates: 08/27/2014 - 02/28/2017
Last Updated: 10/13/2015
Study HIC#: 1301011333